Dr Edward W. Cowen Addresses Current Management of Pustular Psoriasis
January 30th 2022Edward W. Cowen, MD, MHSc, senior clinician and acting branch chief, Dermatology Branch, National Institutes of Health, discusses treatment considerations for patients with different types of pustular psoriasis.
Watch
Study Using Novel Index Links OSA Severity to Higher Cardiovascular Disease Risk
January 29th 2022Patients in upper quartiles of the sleep breathing impairment index, a novel gauge of obstructive sleep apnea (OSA) severity, had higher 10-year Framingham cardiovascular risk than patients whose symptoms were classified as less severe.
Read More
Presence of NAFLD Cirrhosis Impacts Best Response to Immunotherapy in Patients With HCC
January 29th 2022Disease progression was more likely to be the best response to immunotherapy for patients with hepatocellular carcinoma (HCC) and cirrhosis due to nonalcoholic fatty liver disease (NAFLD).
Read More
Study: Adrenal Insufficiency Found in Some MM Patients on Corticosteroid-Based Chemotherapy
January 28th 2022About half of all patients with multiple myeloma (MM) receiving corticosteroid-based chemotherapy were found to have adrenal insufficiency (AI), while identifying suspicious symptoms of AI may be a key component to its detection in this population.
Read More
Report Describes Consequences of Airway Remodeling in Pediatric Nonresponders to Omalizumab
January 28th 2022A recent case report described 3 pediatric patients with severe asthma whose disease was not managed according to care guidelines and who did not respond to the biologic by the time they began therapy.
Read More
Risankizumab Associated With Improved Skin Clearance vs Secukinumab in Moderate to Severe Psoriasis
January 28th 2022Psoriasis Area and Severity Index scores indicated that patients with moderate-to-severe psoriasis had improved skin clearance when treated with risankizumab compared with secukinumab treatment.
Read More
LV Changes, CABG Contribute to Higher Mortality Risk From Heart Failure
January 28th 2022In this new study from China, the link between left ventricular (LV) structural changes and mortality following coronary artery bypass grafting (CABG) was investigated among a patient cohort with heart failure with reduce ejection fraction.
Read More
Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis
January 28th 2022Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following endoscopic sinus surgery.
Read More
Combination Therapy May Prevent Secukinumab Switching in Psoriasis
January 28th 2022Patients with psoriasis who experienced secukinumab secondary failure did not require switching after experiencing significant improvement of daily functioning and quality of life when given a combination rescue therapy.
Read More
Incyte Withdraws FDA Submission for Parsaclisib for FL, MZL, MCL
January 27th 2022Incyte has become the latest company to pull an FDA filing following Gilead and Secura Bio, which both voluntarily withdrew therapies that had been granted accelerated approval but hadn’t completed confirmatory studies for full approval.
Read More
Point-of-Care Testing Has Potential to Expand the Reach of NGS for CRC
January 27th 2022This 9-month investigation looked into the potential for next-generation sequencing (NGS) at the point of care to increase turnaround time for biomarker testing results in advanced colorectal cancer (CRC).
Read More
New Section on Chronic Kidney Disease Risk Management Added to ADA Standard of Care Guidelines
January 27th 2022The American Diabetes Association (ADA) has added a new section to their 2022 Standard of Care guidelines to assist clinicians in managing and preventing the presence of chronic kidney disease and related complications in patients with diabetes.
Read More
Multidisciplinary Care Emphasized for Pregnant Women With SMA
January 27th 2022According to researchers, this case of a patient with spinal muscular atrophy (SMA) from Indonesia was the first to use a collaborative, multidisciplinary approach that involved obstetric, neurology, pediatric, and anesthesiology departments at a hospital.
Read More
Dupilumab Significantly Reduces Hospitalization Rates in Patients With Atopic Dermatitis
January 27th 2022Patients with atopic dermatitis (AD) treated with dupilumab showed reduced hospitalization rates and shorter duration of AD-related hospitalizations vs those treated with control therapies.
Read More